Narrative review reveals shifting histological patterns and low survival in global populations, highlighting distinct epidemiological trajectories between adenocarcinoma and squamous subtypes.
Cancer of the esophagus is the thirteenth most common cancer and the seventh leading cause of cancer-related death worldwide, resulting in approximately 500,000 deaths annually. Population-based 5-year survival has improved in recent decades but rarely exceeds 20%. The main histologic types of esophageal cancer, adenocarcinoma and squamous-cell carcinoma, have different incidence patterns. The past four decades have witnessed a rapidly increasing incidence of esophageal adenocarcinoma in many Western countries, especially among White men, and a decreasing incidence of esophageal squamous-cell carcinoma. In contrast, the opposite is true for most other populations, in which esophageal squamous-cell carcinoma remains the most frequent form. This review focuses on recent developments in the epidemiologic characteristics, risk factors, prevention, and clinical management of esophageal cancer.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: